650579-38-7 Usage
Uses
Used in Pharmaceutical Industry:
4-Morpholinecarboxylic acid, 2-(chloromethyl)-, 1,1-dimethylethyl ester is used as a key intermediate in the synthesis of various pharmaceuticals. Its chemical properties allow it to be incorporated into the structures of different drugs, enhancing their therapeutic effects and pharmacological properties.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Morpholinecarboxylic acid, 2-(chloromethyl)-, 1,1-dimethylethyl ester is utilized as an intermediate in the production of various agrochemicals. Its reactivity and ability to form stable derivatives make it suitable for the development of effective pesticides and other agricultural chemicals.
Used in Organic Synthesis:
4-Morpholinecarboxylic acid, 2-(chloromethyl)-, 1,1-dimethylethyl ester is used as a reagent in organic synthesis for the preparation of a wide range of organic compounds. Its versatility in undergoing various chemical reactions contributes to the synthesis of complex organic molecules for different applications.
Used in Chemical Production:
4-Morpholinecarboxylic acid, 2-(chloromethyl)-, 1,1-dimethylethyl ester serves as a building block in the production of various chemicals, including specialty chemicals and intermediates for further chemical processes. Its presence in the synthesis of these chemicals is crucial for achieving desired properties and functionalities.
Check Digit Verification of cas no
The CAS Registry Mumber 650579-38-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,0,5,7 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 650579-38:
(8*6)+(7*5)+(6*0)+(5*5)+(4*7)+(3*9)+(2*3)+(1*8)=177
177 % 10 = 7
So 650579-38-7 is a valid CAS Registry Number.
650579-38-7Relevant academic research and scientific papers
Receptor-Type Kinase Modulators and Methods of Use
-
Paragraph 0515, (2016/06/06)
The present invention provides compounds for modulating receptor kinase activity, particularly ephrin and EGFR, and methods of treating diseases mediated by receptor kinase activity utilizing the compounds and pharmaceutical compositions thereof. Diseases
CHEMICAL COMPOUNDS
-
Page/Page column 93, (2010/10/20)
The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind specifically to the chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 and/or CCR5 of a target cell.
Indazole-carboxamide compounds
-
Page/Page column 26, (2008/06/13)
The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
